Masao Nawano, Ph.D. and M.B.A., joined the board of directors of TRL in April, 2021. Dr. Nawano begun his career as a pharmacologist in 1994. He led to launch Na+-glucose transport inhibitor as researcher and engaged in research and development of anti-diabetic drugs as research project leader, collaborating with several biotech companies and academia in US and EU. He currently serves as Vice President and General Manager of Strategy and Planning Department in the Sohyaku Division of Mitsubishi Tanabe Pharma Corporation (MTPC). Before that, he has contributed through various roles, such as Director of Corporate Strategy Department of MTPC, Vice President and head of U.S. Business Strategy Department in Mitsubishi Tanabe Holding America, Inc., and Vice President and General Manager of Neuroscience Research Unit in the Sohyaku Division of MTPC. Dr Nawano received his Ph.D. from Tokyo University and his M.B.A. from Kobe University.